Cuardaigh malartuithe:
cancer ready » cancer real (Fairsingigh an Cuardach), cancer renal (Fairsingigh an Cuardach)
transl lung » transoral lung (Fairsingigh an Cuardach), transl dunja (Fairsingigh an Cuardach), cranial lung (Fairsingigh an Cuardach)
cancer read » cancer real (Fairsingigh an Cuardach), cancer renal (Fairsingigh an Cuardach), cancer re (Fairsingigh an Cuardach)
cancer res » cancer re (Fairsingigh an Cuardach), cancer real (Fairsingigh an Cuardach), cancer result (Fairsingigh an Cuardach)
A mostrar 1 - 20 resultados de 1,798 para a pesquisa 'transl lung ((((cancer res) OR (cancer read))) OR (((cancer spread) OR (cancer ready))))', am an iarratais: 1.31seg Refinar resultados
Surrogate clinical endpoints to predict overall survival in non-small cell lung cancer trials—are we in a new era?
Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer

Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis

Impact of sentinel lymph node biopsy in newly diagnosed invasive breast cancer patients with suspicious node: a comparative accuracy survey of fine-needle aspiration biopsy versus core-needle biopsy
Prognostic markers in lung cancer: is it ready for prime time?

Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?
The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

The “liquid biopsy” in non-small cell lung cancer – not quite ready for prime time use
Perifissural nodules: ready for application into lung cancer CT screening?

Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective
Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer—ready for prime time?

Spread through air spaces (STAS): a comprehensive update
Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?

Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?
Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer?

EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
Spread through air spaces in lung neuroendocrine tumor

Uirlisí Cuardaigh: Faigh Fotha RSS — Seol an Cuardach seo mar Ríomhphost — Sábháil an Cuardach